Dramatically Reduced Cost
Using CO2 as a feedstock in cyanobacteria cuts the biggest cost component sugar, making PHB competitive with petroleum plastics.
Poly(3-hydroxybutyrate) (PHB) is a natural, biodegradable polymer belonging to the Polyhydroxyalkanoates (PHAs) family, promising for Bioplastics/Medical applications. However, its commercial use is limited by several drawbacks: PHB is typically brittle; production yield is low, and fermentation cost is high. These issues prevent PHB from competing effectively with petrochemical plastics.
CD Biosynsis employs comprehensive engineering strategies to address these flaws: Genetic Engineering: Knockout PHA Depolymerase genes and TCA cycle genes. This maximizes accumulation and shunts carbon flux towards polymer synthesis. Furthermore, we Introduce Fatty Acid pathway modification to produce PHBV (co-polymer) for improved flexibility. This creates a more versatile bioplastic. Finally, we implement Host Engineering: Utilize Cyanobacteria for CO2 as a cheap carbon source. This phototrophic route lowers feedstock costs dramatically, making PHB production economically viable and highly sustainable.
Get a QuoteCommercialization of PHB faces these key technical and economic barriers:
Genetic and Host Engineering is crucial to improve properties and economics.
CD Biosynsis implements a multi-level strategy for enhanced PHB and PHBV production:
Flux Maximization via Knockouts
We knockout genes responsible for PHA depolymerization and competing pathways e.g. TCA cycle to drive maximum carbon flow to PHB.
PHBV Co-Polymer Modification
We introduce genes from the fatty acid oxidation pathway to incorporate HV monomers e.g. 3-hydroxyvalerate HV to produce flexible PHBV.
Phototrophic Carbon Source Utilization
We engineer Cyanobacteria hosts to utilize low-cost CO2 as the primary carbon source for PHB synthesis, eliminating sugar cost.
Continuous Production Optimization
We design a continuous fermentation system that couples growth and PHB production to avoid costly two-stage batch processes.
Our solution delivers cost-competitive, flexible, and highly sustainable bioplastics.
Our PHB/PHBV engineering service offers these core benefits:
Dramatically Reduced Cost
Using CO2 as a feedstock in cyanobacteria cuts the biggest cost component sugar, making PHB competitive with petroleum plastics.
Improved Bioplastic Flexibility
Producing the PHBV co-polymer reduces brittleness and improves ductility, expanding its use in packaging and films.
Increased Titer and Yield
Genetic knockouts and flux shunting maximize the microbe's efficiency in converting carbon to polymer, boosting overall productivity.
Superior Sustainability
The phototrophic route is carbon negative or neutral, as it utilizes waste CO2 and sunlight, offering the cleanest possible production method.
Reduced Processing Time
Coupling growth and production in a single optimized step eliminates the need for a costly and time-consuming nutrient starvation phase.
We provide a cost-effective, sustainable, and high-performance PHB bioplastic solution.
Our PHB/PHBV engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product stability attributes.
Explore the potential for a cost-competitive, flexible, PHB bioplastic supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is PHB considered brittle and how is PHBV better?
PHB is brittle due to its highly regular structure which results in high crystallinity and stiffness. PHBV is a co-polymer of 3-hydroxybutyrate and 3-hydroxyvalerate HV. The HV monomers act as defects in the crystal lattice, reducing crystallinity and improving toughness and flexibility, making it more like polypropylene PP.
What is the major benefit of using Cyanobacteria for PHB production?
Cyanobacteria are photosynthetic microbes that can use carbon dioxide CO2 and sunlight to grow and produce PHB. This autotrophic pathway replaces expensive organic carbon feedstock e.g. sugars with low-cost CO2, which can be captured from industrial flue gas, thereby making PHB economically viable at a large scale.
What is the role of TCA cycle gene knockouts in the process?
The TCA cycle is the main catabolic pathway that competes with PHB synthesis for intermediates e.g. acetyl-CoA. By knocking out key TCA cycle genes, we force the accumulated carbon intermediates to be channeled exclusively into the PHB biosynthetic pathway, maximizing carbon conversion efficiency.
What is the estimated project timeline?
A comprehensive project involving metabolic engineering PHBV pathway, genetic knockouts, and photobioreactor optimization typically requires 45-55 weeks for final PHBV protocol delivery and polymer property validation.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.